Equity Research, Broker Reports, and media content on SANTHERA PHARMACEUTICALS-REG

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about SANTHERA PHARMACEUTICALS-REG
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on SANTHERA PHARMACEUTICALS-REG. We currently have 0 research reports from 0 professional analysts.

Open
72.5
Volume
0.0m
Range
72.3/73.0
Market Cap
455,289,560m
52 Week
37.1/86.4
Date Source Announcement
19May17 06:00 GNW Santhera Provides Update on Timeline for Application of Raxone® in Duchenne Muscular Dystrophy in Europe
16May17 06:00 GNW Santhera to Present Data and Host Symposium on Pulmonary Function in Duchenne Muscular Dystrophy at the American Thoracic Society 113th Annual Conference
09May17 06:01 GNW Scottish Medicines Consortium Approves Santhera's Raxone® (idebenone) for Restricted Use in Patients with LHON within NHS Scotland
02May17 06:00 GNW Santhera Signs Distribution and Supply Agreement for Raxone® (idebenone) with Pharmathen for Greece and Cyprus
25Apr17 06:00 GNW Santhera becomes Founding Member of the Industry Advisory Council of the United Mitochondrial Disease Foundation
04Apr17 11:48 GNW Santhera's Shareholders Approve all Board Proposals at Annual Shareholders' Meeting
07Mar17 06:00 GNW Santhera Delivered Solid Performance in 2016 and Advances All Programs
  • Frequency of research reports

     

  • Research reports on

    SANTHERA PHARMACEUTICALS-REG

  • Providers covering

    SANTHERA PHARMACEUTICALS-REG